I suspect it’ll drift around until some news eg. possibly a contract win, but more likely the 1H results.
I don’t see much downside. Market would likely gain steadily on proof of EBITDA/revenue returning to historical growth after the pause last year. But, my thesis for holding is for a stronger re-rate gain once some good cross sell wins occur from the Sigma acquisition. That could start at 3 months but more likely 6-12 months away.
Cheers
Ann: Chairman's Address to Shareholders, page-5
Add HSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.24 |
Change
0.150(2.95%) |
Mkt cap ! $1.067B | |||
| Open | High | Low | Value | Volume |
| $5.10 | $5.32 | $5.10 | $3.311M | 630.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2210 | $5.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.25 | 346 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| HSN (ASX) Chart |